Loading
Samay
Samay Health, founded in 2018 by Dr. Maria Artunduaga, is a medtech company based in Mountain View, California. The company focuses on respiratory diagnostics and remote patient monitoring, particularly for Chronic Obstructive Pulmonary Disease (COPD) and Small Airway Disease (SAD). Samay Health combines artificial intelligence and machine learning with medical devices to enhance the detection and management of these conditions. The company's flagship product, Sylvee, is a wearable chest patch that allows for continuous, non-invasive monitoring of lung function at home. It captures lung sounds and provides real-time insights on various respiratory parameters. Sylvee replaces traditional pulmonary tests with a quick, five-minute assessment, making it easier for patients to manage their respiratory health. Samay Health has received over $5 million in funding and holds 12 patents for its innovative technology, positioning it as a leader in respiratory health solutions.
Funding
Every round, secondary, debt facility or acquisition involving Samay that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—